BTS Board Member is Award Finalist
Barry Glassman is one of four finalists for the Community Leadership Award through InvestmentNews, the weekly newspaper for financial advisers. Barry has been involved with the Race for Hope in Washington, DC for nearly a decade and is now a member of the BTS Board of Directors. Congratulations to Barry on this recognition of his devoted service to the brain tumor community!
Tumor Painting Holds Promise
A recently-developed "tumor paint" is 500 times as sensitive as MRIs to tumor tissue. This agent illuminates cancerous cells, giving surgeons clarity by clearly identifying tumor versus healthy brain tissue. Toxicity studies are underway now, and clinical trials should follow soon.
Pass the Garlic
A compound in garlic is effective at destroying GBM cells, a team of researchers will report in this month's Cancer journal. Find out more about how to get the most out of garlic as researchers continue to investigate this connection.
Clinical Trial Update
Valproate and Etoposide for Patients with Brain Metastases Phase I - M.D. Anderson Cancer Center
High-Dose Methotrexate in Young Patients Phase I - National Cancer Institute (NCI)
VNP40101M and Temozolomide in Patients with Progressive or Recurrent Glioma Phase I/II - Robert H. Lurie Cancer Center, NCI
Find other clinical trials based on your interests.
Upcoming Events
October 1 - Annual Meeting and Dinner near Boston
October 28 - Have A Chance Walk in New York City
November 4 - Race for Hope in Philadelphia
Contact the Brain Tumor Society at 800.770.8287 124 Watertown Street, Suite 3H, Watertown MA 02472 http://www.tbts.org/ |